Software to Support Hospital's Expanding Use of Stem Cells in Patient Care
Mediware Information Systems, Inc., a provider of
comprehensive healthcare IT software solutions, announced today that
Yale-New Haven Hospital has selected Mediware's Transtem(TM) software to
support the hospital's cellular therapy program. The Transtem software
provides end-to-end support for hospitals, blood and marrow transplant
programs, cord blood banks and cancer treatment centers, providing
automated support for collecting, testing, manufacturing and storing
cell therapy products, as well as matching and utilizing of these
products for patient care.
The team at Yale-New Haven Hospital initially plans to leverage the
Transtem software to track the use of stem cell products in providing
patient care, monitoring therapies and reporting patient outcomes. Key
factors in the selection include Transtem's comprehensive support of the
entire cellular therapy process; the open nature of the system and its
ability to integrate with other systems and devices; as well as the
credibility and reliability that Mediware has in the industry.
Dr. Edward Snyder, professor of laboratory medicine and director of the
blood bank and stem cell processing laboratory commented: "As stem cell
transplants have increased in frequency and complexity at Yale-New Haven
Hospital it has become essential that we have an information management
solution capable of supporting our unique patient, product and
reporting needs."
In addition to the system's comprehensive capabilities, Transtem is
designed to improve productivity across the organization. Transtem is
web-based and enables Yale-New Haven Hospital laboratory and clinical
teams to obtain access to the same patient, product and outcome
information from other sites, as Yale-New Haven Hospital has expanded
beyond New Haven. Further, the system supports scanning devices and
ISBT-128 barcode labeling of product inventories, reagents and supplies
to allow staff to quickly scan needed products and associate these with
the patient. This eliminates manual data entry, reduces the risk of data
transcription errors and enables dramatic productivity improvements
over paper-based or manual recording. Transtem also enables integration
with other core information systems, such as Yale-New Haven Hospital's
EMR (electronic medical record), for further productivity and safety
benefits.
"As an emerging area of care, our data management and reporting needs
for stem cell transplant are significant," continued Dr. Snyder. "To be
effective, we need to automate our reporting to save time and improve
our productivity. At the same time, we need a solution that allows our
clinicians and researchers easy access to data to perform required
statistical analysis of patient outcomes as part of its role in the NMDP
transplant network."
The Transtem product was designed by industry professionals that work
closely with industry agencies to ensure reporting requirements are
easily and accurately met. In addition to facilitating communication
between caregivers, the software also serves as a bridge to unite
laboratory and clinical teams within a single environment.
Mediware's expansion into cellular therapy technologies continues the
company's nearly 40 year legacy of providing leading edge blood
management technologies. These include the first transfusion management
software system cleared for use in hospital blood banks by the U.S. Food
and Drug Administration, as well as donor recruitment and laboratory
software solutions used by major blood centers.
The company is hosting two informational webcasts to illustrate how the
Transtem software solves the unique challenges that blood and marrow
transplant centers face worldwide. The programs are scheduled for
December 4 and December 6, at 10 am CST. Online registration for either
date is required and is available from Mediware's online event center (
http://mediware.webex.com ).
Additional information about the full range of software capabilities is available online or by emailing info@mediware.com.
About Mediware
Mediware delivers software systems that improve efficiencies and address
safety concerns, enabling healthcare organizations to improve care
processes while decreasing costs. Core Mediware solutions include blood
management technologies for hospitals and blood centers; cell therapy
solutions for cord blood banks, cancer treatment centers and research
facilities; medication management solutions for hospitals, behavioral
health facilities, infusion and specialty pharmacy providers; and
business intelligence-based performance management solutions for
clinical, regulatory and financial aspects of the broader healthcare
market. For more information about Mediware products and services, visit
our website at
www.mediware.com .
The Mediware Information Systems, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=5249
About the Transtem Solution
Transtem was designed by cellular therapy professionals to provide a
comprehensive solution for cell therapy labs, cord blood banks,
transplant centers and academic medical centers to collect, process,
transfuse and track adult and cord blood stem cells used in the
treatment of cancer and blood related diseases. Transtem's unique
capabilities combine a focus on donors, products and patients to provide
a 360-degree view of treatments and outcomes.
This news release was distributed by GlobeNewswire,
www.globenewswire.com
No comments:
Post a Comment